Gynecologic Oncology Expert Witness

A Gynecologic Oncology expert witness is a physician specializing in the diagnosis, surgical treatment, and oncologic management of cancers of the female reproductive system. These experts are frequently retained in litigation involving cervical cancer, ovarian cancer, uterine and endometrial cancer, vulvar cancer, vaginal cancer, delayed diagnosis of gynecologic malignancy, cancer staging, surgical decision-making, chemotherapy, radiation therapy, recurrence, and survivorship care.

Gynecologic Oncology is an ABMS-recognized subspecialty of Obstetrics and Gynecology. Fellowship training emphasizes advanced pelvic surgery, radical hysterectomy, oncologic staging, lymph node assessment, cytoreductive and debulking surgery, and coordination of multimodal cancer care, including chemotherapy and radiation therapy. Many Gynecologic Oncologists maintain active practices in academic cancer centers and tertiary referral hospitals, where they manage complex and high-risk malignancies.

Gynecologic Oncology experts are commonly asked to evaluate care involving cervical cancer screening and diagnosis, HPV-related disease, management of invasive cervical cancer, ovarian cancer presentation and staging, uterine and endometrial cancer diagnosis and treatment, and less common malignancies such as vulvar and vaginal cancer. They also address fertility-sparing treatment considerations in younger patients and adolescents, as well as long-term surveillance and recurrence.

Role of the Gynecologic Oncology Expert Witness

In litigation, Gynecologic Oncology expert witnesses evaluate whether diagnostic evaluation, cancer staging, surgical planning, and oncologic management complied with accepted standards of care. This includes analysis of pathology interpretation, timing and extent of surgery, adequacy of tumor debulking, lymph node evaluation, selection of chemotherapy or radiation therapy, informed consent, and complication management.

Importantly, Gynecologic Oncology experts are frequently retained to provide causation opinions in matters involving delayed diagnosis of gynecologic malignancy. In these cases, the expert assesses whether earlier diagnosis or intervention would more likely than not have altered staging, treatment options, prognosis, or survival. This causation analysis is central in cases involving delayed diagnosis of cervical cancer, ovarian cancer, or uterine cancer.

Key Issues in Gynecologic Oncology Litigation

Gynecologic Oncology cases commonly turn on whether malignancy was timely recognized and appropriately staged. Disputes frequently involve delayed diagnosis of cervical cancer or ovarian cancer, failure to act on abnormal screening or imaging, inadequate staging workup, suboptimal cytoreduction, complications of radical pelvic surgery, chemotherapy-related adverse events, radiation injury, and cancer recurrence or progression.